Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE-NEXT: A Multicenter, Double-Blind, Randomized Controlled Trial.

Adams C, Heard K, Kohli Y, Vatanpour S, Berrouschot J, Buck B, Demchuk A, Dippel D, Dorn F, Field T, Muto M, Pham M, Ryckborst KJ, Swartz RH, van Adel BA, Menon B, Goyal M, Hill MD, Tymianski M, ESCAPE‐NEXT Investigators

Open source

DOI: 10.1161/jaha.125.044080
Published: 2026 Jul 7
Container: Journal of the American Heart Association
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1161/jaha.125.044080,
  title = {Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE-NEXT: A Multicenter, Double-Blind, Randomized Controlled Trial.},
  author = {Adams C and Heard K and Kohli Y and Vatanpour S and Berrouschot J and Buck B and Demchuk A and Dippel D and Dorn F and Field T and Muto M and Pham M and Ryckborst KJ and Swartz RH and van Adel BA and Menon B and Goyal M and Hill MD and Tymianski M and ESCAPE‐NEXT Investigators},
  year = {2026},
  journal = {Journal of the American Heart Association},
  doi = {10.1161/jaha.125.044080},
  url = {https://doi.org/10.1161/jaha.125.044080}
}

RIS

TY  - JOUR
TI  - Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE-NEXT: A Multicenter, Double-Blind, Randomized Controlled Trial.
AU  - Adams C
AU  - Heard K
AU  - Kohli Y
AU  - Vatanpour S
AU  - Berrouschot J
AU  - Buck B
AU  - Demchuk A
AU  - Dippel D
AU  - Dorn F
AU  - Field T
AU  - Muto M
AU  - Pham M
AU  - Ryckborst KJ
AU  - Swartz RH
AU  - van Adel BA
AU  - Menon B
AU  - Goyal M
AU  - Hill MD
AU  - Tymianski M
AU  - ESCAPE‐NEXT Investigators
PY  - 2026
JO  - Journal of the American Heart Association
DO  - 10.1161/jaha.125.044080
UR  - https://doi.org/10.1161/jaha.125.044080
ER  -

APA

C, A., K, H., Y, K., S, V., J, B., B, B., A, D., D, D., F, D., T, F., M, M., M, P., KJ, R., RH, S., BA, V. A., B, M., M, G., MD, H., M, T., & Investigators, E. (2026). Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE-NEXT: A Multicenter, Double-Blind, Randomized Controlled Trial.. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.044080

Source records

pubmed · retrieved 2026-09-27T14:33:04.085Z